2022
DOI: 10.1038/s41431-022-01223-6
|View full text |Cite
|
Sign up to set email alerts
|

Is there a “pandemic effect” on individuals’ willingness to take genetic tests?

Abstract: In this cross-sectional, semi-longitudinal and quasi-experimental study, our goal was to determine the effect of data storage conditions on willingness to take a genetic test. We compared individuals’ preferences regarding how they want to store health data collected from genetic tests through two survey experiments fielded in Switzerland in March 2020 and January 2022. We tested for differences whether genetic data are presented as private goods or public goods. Results confirm our initial research expectatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 23 publications
(27 reference statements)
0
2
0
Order By: Relevance
“…Genetic testing has proved to be a cost‐effective way to diagnose conditions and direct medical resources toward appropriate therapies, surveillance, or treatment, though many barriers and limitations remain implementation of such testing (Muth et al., 2019 ; O'Brien et al., 2021 ; Serrano et al., 2023 ). The COVID‐19 pandemic both exposed these access disparities and eased some barriers by increasing the uptake of telemedicine in genetics clinics, willingness to share genetic information, and to undergoing genetic testing (Deruelle et al., 2023 ; Macalino et al., 2023 ). However, some challenges were exacerbated such as the exclusion of patients without reliable access to the internet or technological literacy to utilize telemedicine (Mann et al., 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Genetic testing has proved to be a cost‐effective way to diagnose conditions and direct medical resources toward appropriate therapies, surveillance, or treatment, though many barriers and limitations remain implementation of such testing (Muth et al., 2019 ; O'Brien et al., 2021 ; Serrano et al., 2023 ). The COVID‐19 pandemic both exposed these access disparities and eased some barriers by increasing the uptake of telemedicine in genetics clinics, willingness to share genetic information, and to undergoing genetic testing (Deruelle et al., 2023 ; Macalino et al., 2023 ). However, some challenges were exacerbated such as the exclusion of patients without reliable access to the internet or technological literacy to utilize telemedicine (Mann et al., 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Two thirds (67%) of the sample is comprised of Swiss Germans and the remaining 33% are from Switzerland's French-speaking region. The data does not take into account the Italian- and the Romansh-speaking regions, representing 8% and less than 1% of the population respectively (Deruelle et al, 2022).…”
Section: Method: Cross-sectional Survey Experimentsmentioning
confidence: 99%
“…These concerns are not unfounded, and it is important to address them. 4 Another concern is the accuracy and reliability of genetic testing. Some individuals may be skeptical about the utility of genetic testing, questioning the implications of such information or the reliability of the results.…”
mentioning
confidence: 99%